CD5L-associated gene analyses highlight the dysregulations, prognostic effects, immune associations, and drug-sensitivity predicative potentials of LCAT and CDC20 in hepatocellular carcinoma
Cancer Cell International,
Abstract Background The dysregulation of CD5L has been reported in hepatocellular carcinoma (HCC).